Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine
Serum rotavirus IgA responses are an imperfect non-mechanistic correlate of protection, and the lack of an accurate serological marker is a challenge to the development of new rotavirus vaccines. Serological responses to rotavirus NSP2 occur following wild-type infection; however, it is unknown if s...
Saved in:
Main Authors: | Daniel Cowley (Author), Daniel Pavlic (Author), Nada Bogdanovic-Sakran (Author), Karen Boniface (Author), Carl D. Kirkwood (Author), Julie E. Bines (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine
by: Daniel Cowley, et al.
Published: (2017) -
Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand
by: Mee-Yew Chen, et al.
Published: (2017) -
Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
by: Nicholas Geard, et al.
Published: (2022) -
Options for improving effectiveness of rotavirus vaccines in developing countries
by: Marion S. Tissera, et al.
Published: (2017) -
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
by: Prashant Kumar, et al.
Published: (2021)